Author | Howard Fillit, MD

Articles

Howard Fillit, MD: Aducanumab Findings Lead the Way in Dementia

May 20, 2020

The founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation discussed the landmark findings from Biogen on its agent aducanumab and the impact the trial might have on the future.

Howard Fillit, MD: Telemedicine and Tech in the Future Care of Alzheimer and Dementia

May 06, 2020

The founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation detailed what he foresees the future of Alzheimer and dementia care to look like with telemedicine as a more permanent aspect of care.

Howard Fillit, MD: The Positives of Telemedicine Adoption for Geriatric Patients

May 02, 2020

The founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation spoke to the way the COVID-19 pandemic has transformed the use of telemedicine for the elderly with conditions like Alzheimer and dementia.